| Financial Year |
March 31 2023 |
| Monetary Funds |
184,920,022.78 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,243,346.37 |
| Accounts Receivable |
503,188,519.11 |
| Advances to Suppliers |
16,187,042.89 |
| Other Receivables |
167,154,653.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
118,528,905.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,311,855.09 |
| Total Current Assets |
1,111,270,020.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,104,326.89 |
| Investment Properties |
112,590,793.06 |
| Fixed Assetes |
76,557,692.04 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,651,026.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
26,469,891.06 |
| Deferred Income Tax Assets |
39,656,053.43 |
| Other Non-Current Assets |
4,484,339.61 |
| Sub-Total of Non-Current Assets |
312,215,070.87 |
| Total Assets |
1,423,485,091.29 |
| Short-Term Loans |
147,097,661.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
711,985,577.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,900,160.58 |
| Taxes Payable |
72,090,700.03 |
| Interest Payable |
-- |
| Dividend Payable |
3,159,149.71 |
| Other payables |
110,262,095.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,839,309.01 |
| Other Current Liabilities |
2,074,709.95 |
| Sub-Total of Current Liabilities |
1,115,608,808.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
47,530,542.24 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
79,725,576.50 |
| Total Liabilities |
1,195,334,385.26 |
| Paid-In Capital(Or Share Stock) |
138,756,240.00 |
| Capital Surplus |
101,982,193.26 |
| Surplus Reserve |
50,489,790.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-170,163,041.49 |
| Minority Stockholder's Interest |
106,761,469.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
121,389,236.91 |
| Owner's Equity（Stockholder's Equity） |
228,150,706.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,423,485,091.29 |
